This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Boehringer Ingelheim GmbH
Drug Names(s): BI 811283
Description: BI 811283 is a small molecule inhibitor of the serine/threonine protein kinase, Aurora kinase, and potentially has antineoplastic activity. BI 811283 binds to and inhibits Aurora kinases, resulting in disruption of the assembly of the mitotic spindle apparatus, disruption of chromosome segregation, and inhibition of cell proliferation.
BI 811283 News
Pink Sheet In Brief: PhRMA state government relations
Additional information available to subscribers only: